Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Radiation-free FEVAR with LumiGuide image guidance

Official title: Radiation Free Study

Run by Philips Clinical & Medical Affairs Global · NCT06549348 · Data updated 2026-11-12

This study will test whether using LumiGuide instead of standard fluoroscopy cuts X‑ray time during fenestrated endovascular aortic repair for adults who need visceral artery incorporation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment182 (estimated)
SponsorPhilips Clinical & Medical Affairs Global
Industry-sponsored
Locations11 sites (Birmingham, Alabama and 10 other locations)
StatusRecruiting
StartedJuly 3, 2025
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJune 15, 2026
Trial IDNCT06549348 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) undergoing a primary FEVAR that includes incorporation of visceral arteries (celiac, SMA, renal), able to give informed consent, with life expectancy ≥2 years, and meeting the trial's vessel-count and timing criteria are ideal candidates.

Probably not a fit

Patients undergoing branched or iliac branched device procedures, staged or re-intervention FEVAR, emergent (<24 hr) repairs, treatment of more than four target vessels, or those with connective tissue disorders are excluded and unlikely to benefit from this trial's approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, unblinded, multicenter comparison of LumiGuide image guidance versus conventional fluoroscopy during fenestrated endovascular aortic repair (FEVAR). Sites were chosen across the US and Europe to improve generalizability. The primary endpoint is average procedure fluoroscopy time measured for procedures that incorporate the celiac trunk, superior mesenteric artery, and renal arteries. Participants are adult patients undergoing primary FEVAR who meet vessel and timing eligibility and are randomized to LumiGuide or standard fluoroscopy guidance.

Why it matters

Potential benefit: If successful, the approach could substantially reduce patients' and staff's radiation exposure during complex aortic repair and may shorten imaging time.

How similar studies have gone: Prior studies of fusion imaging and navigation systems have shown reductions in fluoroscopy time for endovascular procedures, but randomized data specifically on LumiGuide are limited, making this a relatively novel randomized comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject will be undergoing a primary Fenestrated Endovascular Aortic Repair (FEVAR) procedure (including subjects with prior infrarenal EVAR or open repair) that includes the incorporation of visceral arteries into the repair.
* Subject is able to give informed consent and is 18 years of age or older, or of legal age to give informed consent per state or national law.
* Subject has a life expectancy of at least 2 years
* Target vessels to be included are the Celiac Trunk, Superior Mesenteric Artery and Renal Arteries

Exclusion Criteria:

* Subjects undergoing an endovascular procedure that include branches or iliac branched devices (IBD) in the repair
* Subject treated for re-intervention / staged procedure post-primary FEVAR procedure
* Subjects intended to be treated for more than 4 target vessels (not counting the contralateral gate)
* Subject treated for an emergent (\<24hrs after emergence) procedure
* Subject with connective tissue disorder eg, Marfan's or Ehlers Danlos Syndrome
* Subject with contrast allergies
* Subject participates in a potentially confounding drug or device trial during the course of the study. Co-enrollment in concurrent trials may be allowed provided that pre-approval is obtained from Philips.
* All vulnerable subjects such as immuno-compromised subjects, subjects lacking the capacity to provide consent, patients in emergency situations, pregnant or breast-feeding women, or any other subject who meets an exclusion criteria, according to applicable national laws, if any.
* Subject unwilling or unable to comply with the protocol unable to understand verbal and/or written informed consent

Where it's running

  • University of Alabama
    Birmingham, Alabama, United States
    Recruiting
  • University of Massachusetts
    Worcester, Massachusetts, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • University of Texas Southwestern Medical Center
    Dallas, Texas, United States
    Recruiting
  • UZ Gent
    Ghent, Belgium
    Recruiting
  • Hôpital Universitaire Pitié-Salpêtrière
    Paris, France
    Recruiting
Show 5 more locations
  • UMC Maastricht
    Maastricht, Netherlands
    Recruiting
  • Guys & St Thomas
    London, United Kingdom
    Recruiting
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Not yet recruiting
  • Rigshospitalet University Hospital
    Copenhagen, Denmark
    Not yet recruiting
  • University Medical Center Utrecht
    Utrecht, Netherlands
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.